Study: standard preoperative fasting guidelines safe for GLP-1 patients
Editor's Note Preoperative use of GLP-1 receptor agonists (RA) medications such as Ozempic and Wegovy is safe, according to a study published in the June issue of the American Journal of Gastroenterology. Controversy has swirled around these drugs due to the risk of slowed stomach emptying increasing a patient’s odds…
Study: Ozempic slows disease, reduces cardiovascular risk in CKD, diabetes patients
Editor's Note Semaglutide, the active ingredient in Ozempic diabetes treatment and Wegovy weight-loss treatment, outperformed a placebo and demonstrated capacity to reduce risk of death from kidney-related or cardiovascular causes in a recent study of patients with type 2 diabetes and chronic kidney disease spearheaded by manufacturer Novo Nordisk. Published…
Study: Weight-loss drug semaglutide boosts repeat surgery risk
Editor's Note Popular weight-loss \ drug semaglutide could significantly increase risk for repeat operations patients with diabetes who undergo lumbar surgery. According to a May 8 report in Medscape Medical News, the findings are pending review for publication and reportedly provides the first evidence on the impact of semaglutide on…
Free Daily News
- Novel noninvasive surgical approach shows promise in treating severe OCD
- Study: Preop mental health assessment improves postop outcomes for older patients
- Study: Adenotonsillectomy reduces healthcare use in children with mild sleep-disordered breathing
- Introducing New Leader Toolkit: Your guide to OR leadership success
- Northwestern tests autonomous blood draw robot
- Unplanned hospital admissions post ASC visits remain exceptionally low, study finds
- Cardiology efficiency, orthopedic revenue surge as ASCs navigate growing complexity
- Study: BMI, hidden tumors complicate intubation
- New 7T MRI technique pinpoints hidden epilepsy-causing brain lesions
- Wildfires linked to longer postop hospital stay following lung cancer surgery, study finds